The Epilepsy Prescribers Guide To Antiepilepticdrugs 3rd Edition Philip Npatsalos by Philip N. patsalos, Erik K. st. louis 9781108453202, 1108453201 instant download after payment.

The purpose of the i rst and second edition of The Epilepsy Prescriber’s Guide
to Antiepileptic Drugs was to help those involved in the treatment of patients
with epilepsy to meet the challenge of having easy access to all relevant
aspects of every antiepileptic medication currently available, including the
newest ones. The Prescriber’s Guide has been very well received, and the
feedback indicates that the stated goal was met at the time. Four years on
from the second edition, the authors now recognize the need for a new
edition in order to continue to keep up with the original goal. Up- to- date
new information has been added accordingly, with no change in the easy-
to- use format.
One section has been added to the book in order to cover the new drug
that has become available in the meantime, brivaracetam, and another
(retigabine/ ezigabine) has been deleted because it has been withdrawn
from the market. All sections on pharmacokinetic interactions, as well as
the table at the end of the book summarizing all known pharmacokinetic
interactions between antiepileptic drugs, have been extensively updated, and
they represent a most comprehensive and up- to- date source of information
on pharmacokinetic interactions involving antiepileptic drugs. Suggested
pediatric dosage schedules have been added for several drugs. Additional
adverse ef ects, as well as recommended precautions and monitoring, were
added where applicable. The issue of bone health, as well as vitamin D
monitoring and supplementation, was addressed for selected drugs, and
uses in special populations have been updated where relevant. Information
on teratogenicity reported in recent publications and pregnancy registries
was incorporated in the sections on pregnancy. Finally, for these multiple
upgrades, the relevant references were added to the list of suggested reading